ABOUT ELLIGO HEALTH RESEARCH
Elligo Health Research accelerates clinical trials through healthcare with access to over 150 million known patients and their HIPAA-compliant healthcare data, our IntElligo® Research Stack technology, and our PatientSelect identification and engagement model. Coupled with the largest Known Patient Access Network, Elligo’s Site Solutions enable healthcare practices and research sites to participate in clinical trials. By adaptive engagement of known patients and physicians, we accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.
WEBINARS AND VIDEOS
Elligo Health Research® is the ultimate patient provider, giving you immediate access to known, diverse patients so you can quickly get your product to the people who desperately need it.
This webinar will feature industry leaders from the U.S. Food and Drug Administration (FDA), Freenome, Cerner Enviza, Deep Lens, and Elligo Health Research®. The discussion will also explore potential pitfalls of healthcare data as well as solutions and strategies for overcoming them.
During this presentation, learn how a patient-first approach that maintains the trusted physician/patient relationship is the way to access the 97% of patients that have never been involved in a clinical trial.
In an industry notoriously resistant to systemic change, there are many opportunities to employ emerging technologies — to the great benefit of patients and research teams alike.
Elligo’s Chief Scientific Officer Rebecca Kush, Ph.D., discusses leveraging EHRs and community practices to accelerate patient-focused decentralized clinical trials.
Elligo’s decentralized trial process accesses 150+ million patients and their EHR data to identify qualified patients and bring on as many healthcare providers as needed to accelerate enrollment and execute studies 10x faster than anyone else.
IntElligo® Research Stack technology is the only system designed to work in a real-world healthcare environment, collecting data at the point of care using CDISC global research data standards and automatically preparing it for regulatory compliance and submission.
Decentralized clinical trials (DCTs), which were encouraged by the FDA as a means to modernize clinical trials per the 21st Century Cures Act, have received new interest during the pandemic. Consideration for safety of study participants and clinicians in this changing world demands a new paradigm for research. In this webinar you will learn more about the characteristics of DCTs and hybrid trials, a spectrum of approaches to DCTs, SDR and how it aligns with risk-based monitoring and differs from source data verification (SDV), and opportunities to leverage eSource technology.
The COVID-19 pandemic has made the benefits of decentralized or hybrid trial models even more obvious, and as travel restrictions, social distancing and the overall strain on the healthcare system became more evident, the FDA updated regulations to fast-track research, openly recognizing the value of alternative technology such as virtual trial capabilities in clinical research. This webinar will explore how COVID-19 pushed the industry to adapt to tech-enabled solutions for patients and sponsors.
New treatment options can only become realities when clinical trials are fully enrolled. Learn how Elligo is improving access to clinical trials for patients by bringing research as care options to their physician’s office.
CONTACT INFORMATION
Elligo Health Research
11612 Bee Cave Road, Bldg. 1, Ste. 150
Austin, TX 78738
UNITED STATES
Phone: (512) 580-4633
Contact: Hannah Hauser
BROCHURES
- Elligo’s Patient Travel Services
- Enable Your Clinical Trial Through Healthcare
- Accelerate Psychedelic Research With A Pioneered Site Network
- Only Elligo Mitigates Research Risk
- Elligo’s DataAI Connect Enables Rapid, Data-Driven Clinical Research
- Elligo's Customizable Solutions For Sponsors
- Optimize Your Research Site’s Growth And Financial Success
- PatientSelect Trials
- PatientSelect : Direct Access To Patients And Their Health Data
- Only Elligo
- How To Accelerate Your Clinical Trial Through Healthcare
FEATURED ARTICLES
-
![GettyImages-1391303942 patient doctor HCP]( "3 Steps For Internal Or Family Medicine Clinical Trials Enrollment")
If 25% of U.S. adults don’t have a primary care provider, how can you access enough patients to fill your internal or family medicine clinical trial? Here are 3 tips.
-
![Test Tube Blood Samples GettyImages-177440807]( "Patient Engagement: Early Cancer Detection Blood Draw")
Discover how we aided a pharmaceutical company in enrolling participants for a Phase III trial, DETECT-ASCEND 2, focused on Plasma-Based CancerSEEK Testing for early cancer detection.
-
![Medical Research Scientist-GettyImages-1050311790]( "Can Patient-Led Clinical Trial Design Save Neurology Research?")
What is causing high fail rates, and what are the best opportunities for sponsors to turn them around? See how understanding the factors can help sponsors navigate and improve outcomes in neurology clinical trials.
-
![Patient-docdtor-healthcare-GettyImages-1432735132]( "Solutions To Clinical Trial Travel")
Read why the increase in travel distance, time, and frequency suggests patient travel is a bigger barrier to patient recruitment and retention than the industry previously thought.
-
![GettyImages-1389580785 patient tech]( "Will FDORA Impact My Clinical Research Practice?")
Explore the details of each provision of the FDA Omnibus Reform Act of 2022 to better understand and navigate the evolving regulatory framework, ensuring compliance and optimal functioning in the realm of clinical trials.
-
![Diversity-GettyImages-1323880880]( "3 Strategies For Increasing Diversity In Psychedelic Research")
Psychedelic research has about 18.4% total minority participation—less than half of the average 38.2% country-level representation. Increase racial and ethnic diversity with these three proven strategies.
-
![GettyImages-1278800031 diverse trial participants]( "The Easiest Way To Meet the FDA’s Clinical Trial Diversity Requirement")
Explore how this innovative approach to navigating FDORA streamlines the diversity action plan process while placing a strong emphasis on patient-centricity.
-
![Medical research-GettyImages-1287846309]( "Best Practices For Quality, Compliant Clinical Trials")
It’s simple: Quality research is nonnegotiable. Gain insights into how teams can ensure all aspects of their trial are high quality, will withstand scrutiny, and protect the patient.
-
![GettyImages-1359273311 office]( "7 Essential Steps On The Promising Path Of Psychedelic Therapy")
Understand why it is imperative to reevaluate and transform mental health treatment, offering individuals the effective and comprehensive care they so desperately require—and how to do it.
-
![GettyImages-1134045154 customer success]( "3 Best Practices For Site Success")
As research paradigms continue to develop, sites will want to utilize this collection of indispensable approaches as a blueprint for achieving resounding success within the ever-evolving clinical landscape.
